PDB ID 1A37     CHAIN A
Protein name 14-3-3 PROTEIN ZETA
Uniprot Accession P63103
The number of similar proteins 127
The number of binding states 12
The number of binding partners 10

Coloring

Unicolor (beige)

The number of binding partners

Group

Downdload

Format:

Molecule viewer


Only interaction residues
#binding
partners
  >9
  8
  7
  6
  5
  4
  3
  2
  1
  0

Sequence information

1   MDKNELVQKA   KLAEQAERYD   DMAACMKSVT   EQGAELSNEE   RNLLSVAYKN   50
51   VVGARRSSWR   VVSSIEQKTE   GAEKKQQMAR   EYREKIETEL   RDICNDVLSL   100
101   LEKFLIPNAS   QAESKVFYLK   MKGDYYRYLA   EVAAGDDKKG   IVDQSQQAYQ   150
151   EAFEISKKEM   QPTHPIRLGL   ALNFSVFYYE   ILNSPEKACS   LAKTAFDEAI   200
201   AELDTLSEES   YKDSTLIMQL   LRDNLTLWTS   DTQGDEAEAG   EGGEN   250

Variants

Residue AA Source /
dbSNP
Clinical
Significance
Allele
Frequency
(> 0.0001)
AlphaMissense
pathogenicity
Disease name
14_GLU TER ClinVar
chr8:101961078
rs775309705
Pathogenic - - Popov-Chang syndrome [MONDO:MONDO:0979865,MedGen:CN380660,OMIM:618428]
49_LYS ASN ClinVar
chr8:101960971
-
Pathogenic - - Popov-Chang syndrome [MONDO:MONDO:0979865,MedGen:CN380660,OMIM:618428]
75_LYS GLN gnomAD
chr20:43530403
rs142757633
- 0.00180995 - -
75_LYS GLN 8.3kJPN
chr20:43530403
rs142757633
- 0.0003 - -
95_ASN SER 8.3kJPN
chr20:43530464
rs749944173
- 0.0001 - -
108_ASN SER gnomAD
chr20:43532662
rs151038182
- 0.000869624 - -
108_ASN SER 8.3kJPN
chr8:101937239
rs544713098
- 0.0001 - -
127_ARG CYS ClinVar
chr8:101937183
-
Pathogenic - - not provided [MedGen:C3661900]
134_ALA VAL 8.3kJPN
chr8:101937161
-
- 0.0001 - -
143_ASP HIS 8.3kJPN
chr8:101936518
-
- 0.0001 - -
145_SER LEU ClinVar
chr8:101936511
rs754522887
Pathogenic - - Popov-Chang syndrome [MONDO:MONDO:0979865,MedGen:CN380660,OMIM:618428]
(Powered by wupsivus)

Reference

PiSite: a database of protein interaction sites using multiple binding states in the PDB, Miho Higurashi, Takashi Ishida and Kengo Kinoshita, Nucleic Acids Research 2009 37(Database issue):D360-D364

COPYRIGHTc2008-2019 Miho Higurashi, Takashi Ishida and Kengo Kinoshita. All rights reserved.